15-30941883-G-C
Position:
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_017762.3(MTMR10):āc.1921C>Gā(p.Leu641Val) variant causes a missense change. The variant allele was found at a frequency of 0.0000917 in 1,614,060 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.00047 ( 0 hom., cov: 32)
Exomes š: 0.000053 ( 0 hom. )
Consequence
MTMR10
NM_017762.3 missense
NM_017762.3 missense
Scores
1
6
12
Clinical Significance
Conservation
PhyloP100: 3.67
Genes affected
MTMR10 (HGNC:25999): (myotubularin related protein 10) Predicted to enable phosphatidylinositol-3-phosphatase activity. Predicted to be involved in phosphatidylinositol dephosphorylation. Located in cytoplasm. [provided by Alliance of Genome Resources, Apr 2022]
FAN1 (HGNC:29170): (FANCD2 and FANCI associated nuclease 1) This gene plays a role in DNA interstrand cross-link repair and encodes a protein with 5' flap endonuclease and 5'-3' exonuclease activity. Mutations in this gene cause karyomegalic interstitial nephritis. Alternatively spliced transcript variants encoding distinct isoforms have been described. [provided by RefSeq, Feb 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -2 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.038619995).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MTMR10 | NM_017762.3 | c.1921C>G | p.Leu641Val | missense_variant | 16/16 | ENST00000435680.6 | NP_060232.2 | |
FAN1 | NM_014967.5 | c.*321G>C | 3_prime_UTR_variant | 15/15 | ENST00000362065.9 | NP_055782.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MTMR10 | ENST00000435680.6 | c.1921C>G | p.Leu641Val | missense_variant | 16/16 | 1 | NM_017762.3 | ENSP00000402537.1 | ||
FAN1 | ENST00000362065.9 | c.*321G>C | 3_prime_UTR_variant | 15/15 | 1 | NM_014967.5 | ENSP00000354497.4 |
Frequencies
GnomAD3 genomes AF: 0.000466 AC: 71AN: 152234Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
71
AN:
152234
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000122 AC: 30AN: 246816Hom.: 0 AF XY: 0.0000895 AC XY: 12AN XY: 134112
GnomAD3 exomes
AF:
AC:
30
AN:
246816
Hom.:
AF XY:
AC XY:
12
AN XY:
134112
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000527 AC: 77AN: 1461708Hom.: 0 Cov.: 33 AF XY: 0.0000605 AC XY: 44AN XY: 727136
GnomAD4 exome
AF:
AC:
77
AN:
1461708
Hom.:
Cov.:
33
AF XY:
AC XY:
44
AN XY:
727136
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000466 AC: 71AN: 152352Hom.: 0 Cov.: 32 AF XY: 0.000430 AC XY: 32AN XY: 74498
GnomAD4 genome
AF:
AC:
71
AN:
152352
Hom.:
Cov.:
32
AF XY:
AC XY:
32
AN XY:
74498
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ESP6500AA
AF:
AC:
5
ESP6500EA
AF:
AC:
0
ExAC
AF:
AC:
16
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 23, 2023 | The c.1921C>G (p.L641V) alteration is located in exon 16 (coding exon 16) of the MTMR10 gene. This alteration results from a C to G substitution at nucleotide position 1921, causing the leucine (L) at amino acid position 641 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Uncertain
DEOGEN2
Benign
T
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Pathogenic
D
LIST_S2
Uncertain
D
M_CAP
Benign
D
MetaRNN
Benign
T
MetaSVM
Benign
T
MutationAssessor
Uncertain
M
PrimateAI
Benign
T
PROVEAN
Benign
N
REVEL
Benign
Sift
Uncertain
D
Sift4G
Benign
T
Polyphen
D
Vest4
MVP
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at